Revlimid

Medicinal product

(Invented) name

Revlimid

Active substance (s)

Lenalidomidas

Strength

2,5 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AX04, Lenalidomide

Marketing authorisation holder

Bristol-Myers Squibb Pharma EEIG, Airija

Date of authorisation

2007-06-14

Date of renewal

Documents

Revlimid mokomoji medziaga pacientams.pdf

Revlimid pranesimo apie nestuma forma.pdf

Revlimid mokomoji medziaga sveikatos prieziuros specialistams.pdf

Revlimid paciento kortele.pdf

Paciento patvirtinimo dokumentas.pdf

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Capsule, hard	1 vnt.
Lenalidomidas	2,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
53930	67916	1067916	lizdinė plokštelė	N21		Receptinis	EU/1/07/391/005	Netiekiama	-	-	No	-	-
58049	72173	1072173	lizdinė plokštelė	N7		Receptinis	EU/1/07/391/007	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2007-06-14	Registruotas